We have shown that immunohistochemical assessment of WRAP53 protein using C1‐antibody is prognostic in early‐stage breast cancer, as low nuclear levels were associated with a higher incidence of locally recurrent cancer and death from breast cancer. Here, WRAP53 is linked to cancer.